Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

This study is currently recruiting participants.
Verified November 2013 by University Hospital Inselspital, Berne
Sponsor:
Collaborator:
University of Bern
Information provided by (Responsible Party):
Sebastian Wolf, University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00564291
First received: November 26, 2007
Last updated: November 8, 2013
Last verified: November 2013
  Purpose

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy


Condition
Macular Edema
CNV

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation of Retinal Structure With High Resolution OCT

Resource links provided by NLM:


Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • Integrity of retinal layers [ Time Frame: End of study ] [ Designated as safety issue: No ]

Estimated Enrollment: 700
Study Start Date: January 2007
Estimated Study Completion Date: November 2015
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Healthy volunteers
2
CSME secondary to diabetic retinopathy
3
ARMD with CNV before and after therapy
4
ARMD atrophic
5
Retinal vein occlusion
6
retinitis pigmentosa
7
vitreoretinal proliferation

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

healthy subjects and patients with macular diseases

Criteria

Inclusion Criteria:

  • Macular disease
  • Healthy subjects
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00564291

Contacts
Contact: Ute Wolf-Schnurrbusch, MD ute.wolf@insel.ch

Locations
Switzerland
Klinik und Poliklinik für Augenheilkunde, University Bern Recruiting
Bern, Switzerland
Principal Investigator: Ute Wolf-Schnurrbusch, MD         
Sponsors and Collaborators
Sebastian Wolf
University of Bern
Investigators
Principal Investigator: Ute Wolf-Schnurrbusch, MD University of Bern
Study Director: Sebastian Wolf, MD PhD University of Bern
  More Information

No publications provided by University Hospital Inselspital, Berne

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Sebastian Wolf, Director, University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT00564291     History of Changes
Other Study ID Numbers: KEK 044/07
Study First Received: November 26, 2007
Last Updated: November 8, 2013
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:
OCT

Additional relevant MeSH terms:
Edema
Macular Edema
Signs and Symptoms
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on April 14, 2014